Market Overview:
The global pancreatic cancer treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of pancreatic cancer, technological advancements in the field of pancreatic cancer treatment, and rising awareness about pancreatic cancer. The global pancreatic cancer treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into chemotherapy, targeted therapy, and others. On the basis of application, the market is segmented into hospital and clinic. The regional segments are North America (U.S., Canada), Latin America (Mexico), Europe (Germany), Asia Pacific (China), Middle East & Africa (Saudi Arabia).
Product Definition:
Pancreatic cancer treatment is the process of diagnosing and managing pancreatic cancer. Treatment may include surgery, chemotherapy, radiation therapy, and/or targeted therapy.
Chemotherapy:
Chemotherapy is a group of medical treatment used to treat cancer. Chemotherapies mainly include drugs and biologics. Biologic therapies are made up of antibodies and interleukins, which stimulate the immune system to act against cancer cells.
Targeted Therapy:
Targeted therapy is a type of cancer treatment that involves the delivery of drugs to specific areas or organs affected by cancer. In pancreatic cancer, the drug therapies are used for treating different types of tumors in different parts of the body. The most common symptom associated with pancreatic tumor is abdominal pain; therefore, it's easier to treat if it's found early. There are two types of treatments available-surgery and targeted therapy (chemotherapy).
Application Insights:
The hospital application segment dominated the market for pancreatic cancer treatment and accounted for a revenue share of around 60.0% in 2017. The high prevalence of chronic diseases, such as diabetes and obesity, is expected to be the major factor driving the hospital application segment over the forecast period. In addition, an increase in screening programs is anticipated to further drive this segment over the forecast period.
Clinic applications are expected to witness significant growth with a CAGR of XX% from 2018 to 2030 owing to increasing awareness about early diagnosis.
Regional Analysis:
North America dominated the global pancreatic cancer treatment market in 2017. This can be attributed to the presence of key players, availability of novel drugs, high healthcare expenditure and better patient reimbursement scenario as compared to other regions. Moreover, higher adoption of technologically advanced products is also expected to drive growth during the forecast period.
Asia Pacific is estimated to witness lucrative growth over the forecast period owing to rising disposable income and improving healthcare infrastructure in emerging countries such as China and India. Furthermore, an increase in awareness about early diagnosis coupled with government initiatives for raising funds for pancreatic cancer research are some factors anticipated boost regional growth during the forecast period.
Growth Factors:
- Increasing incidence of pancreatic cancer
- Rising awareness about pancreatic cancer and its treatment options
- Growing demand for better and more effective treatments for pancreatic cancer
- Availability of new and innovative therapies for the treatment of pancreatic cancer
- increasing investment in research and development for the treatment of pancreatic cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Pancreatic Cancer Treatment Market Research Report
By Type
Chemotherapy, Targeted Therapy, Others
By Application
Hospital, Clinic
By Companies
Eli Lilly, Celgene, Roche, Amgen, Novartis, PharmaCyte Biotech, Clovis Oncology, Teva, Merck, Pfizer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Pancreatic Cancer Treatment Market Report Segments:
The global Pancreatic Cancer Treatment market is segmented on the basis of:
Types
Chemotherapy, Targeted Therapy, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Eli Lilly
- Celgene
- Roche
- Amgen
- Novartis
- PharmaCyte Biotech
- Clovis Oncology
- Teva
- Merck
- Pfizer
Highlights of The Pancreatic Cancer Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Chemotherapy
- Targeted Therapy
- Others
- By Application:
- Hospital
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Pancreatic Cancer Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
There is no one-size-fits-all answer to this question, as the best pancreatic cancer treatment will vary depending on the individual's specific situation and health condition. However, some common treatments for pancreatic cancer include surgery, chemotherapy, and radiation therapy.
Some of the major players in the pancreatic cancer treatment market are Eli Lilly, Celgene, Roche, Amgen, Novartis, PharmaCyte Biotech, Clovis Oncology, Teva, Merck, Pfizer.
The pancreatic cancer treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Pancreatic Cancer Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Pancreatic Cancer Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Pancreatic Cancer Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Pancreatic Cancer Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Pancreatic Cancer Treatment Market Size & Forecast, 2018-2028
4.5.1 Pancreatic Cancer Treatment Market Size and Y-o-Y Growth
4.5.2 Pancreatic Cancer Treatment Market Absolute $ Opportunity
Chapter 5 Global Pancreatic Cancer Treatment Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Pancreatic Cancer Treatment Market Size Forecast by Type
5.2.1 Chemotherapy
5.2.2 Targeted Therapy
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Pancreatic Cancer Treatment Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Pancreatic Cancer Treatment Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Pancreatic Cancer Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Pancreatic Cancer Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Pancreatic Cancer Treatment Analysis and Forecast
9.1 Introduction
9.2 North America Pancreatic Cancer Treatment Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Pancreatic Cancer Treatment Market Size Forecast by Type
9.6.1 Chemotherapy
9.6.2 Targeted Therapy
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Pancreatic Cancer Treatment Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Pancreatic Cancer Treatment Analysis and Forecast
10.1 Introduction
10.2 Europe Pancreatic Cancer Treatment Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Pancreatic Cancer Treatment Market Size Forecast by Type
10.6.1 Chemotherapy
10.6.2 Targeted Therapy
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Pancreatic Cancer Treatment Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Pancreatic Cancer Treatment Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Pancreatic Cancer Treatment Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Pancreatic Cancer Treatment Market Size Forecast by Type
11.6.1 Chemotherapy
11.6.2 Targeted Therapy
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Pancreatic Cancer Treatment Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Pancreatic Cancer Treatment Analysis and Forecast
12.1 Introduction
12.2 Latin America Pancreatic Cancer Treatment Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Pancreatic Cancer Treatment Market Size Forecast by Type
12.6.1 Chemotherapy
12.6.2 Targeted Therapy
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Pancreatic Cancer Treatment Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Pancreatic Cancer Treatment Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Pancreatic Cancer Treatment Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Pancreatic Cancer Treatment Market Size Forecast by Type
13.6.1 Chemotherapy
13.6.2 Targeted Therapy
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Pancreatic Cancer Treatment Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Pancreatic Cancer Treatment Market: Competitive Dashboard
14.2 Global Pancreatic Cancer Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Eli Lilly
14.3.2 Celgene
14.3.3 Roche
14.3.4 Amgen
14.3.5 Novartis
14.3.6 PharmaCyte Biotech
14.3.7 Clovis Oncology
14.3.8 Teva
14.3.9 Merck
14.3.10 Pfizer
